RESUMO
While people are familiar with the practice of declawing domestic cats, "onychectomy", as it is also known, is also performed on non-domesticated species, including pantherines, to prolong their use for entertainment purposes. Although the surgery (the partial or complete removal of the distal phalanx) has clear osteological implications, its myological effects have never been studied. As the mass of an animal increases cubically as a product of its volume, while the areas of its paws only increase as a square, larger felids have higher foot pressures and, therefore, the surgery may have particularly substantial functional effects on larger cats. In this study, we evaluate the forearms of clawed and declawed non-domestic felid specimens that spanned the body size range of the whole family to evaluate the effects of onychectomy on muscle fiber architecture. We found that the deep digital flexors (the muscles most directly affected by onychectomy) of declawed felids are significantly lighter (~73%) and less powerful (46-66%) than those of non-declawed felids, while other muscles do not make up for these reductions. Thus, onychectomy has a substantial effect on the myological capabilities of cats, and because these deficiencies are not compensated for in biomechanically disadvantaged larger felids, it probably has even more functionally devastating consequences for these species.
RESUMO
This study was conducted to evaluate whether the administration of naloxone (NAL) had an impact on the speed or quality of recovery in servals anesthetized with ketamine, butorphanol, and medetomidine. Twenty-two clinically healthy, captive servals (Leptailurus serval) were anesthetized for routine physical examinations using ketamine (3 mg/kg), medetomidine (0.03 mg/kg), and butorphanol (0.3 mg/kg). Eleven animals were administered atipamezole (5 mg/mg medetomidine) and NAL (0.1 mg/mg butorphanol), while the other 11 were administered atipamezole (5 mg/mg medetomidine) and sterile saline (SAL). There was no statistically significant difference in recovery time between the NAL and the SAL group; similarly, there were no significant differences between groups at any time point for the measures of quality of recovery used in this study. This investigation was unable to detect a clinically significant difference in anesthetic recovery for servals that received NAL relative to those that did not. These results suggest that butorphanol does not routinely need to be antagonized in captive servals that are anesthetized with these dosages of ketamine, medetomidine, and butorphanol. It may be more important to administer opioid antagonists in free-ranging animals, where residual sedation would be more detrimental. In these cases, a long-acting antagonist, such as naltrexone, may be indicated. An opioid antagonist, such as NAL or naltrexone, should always be available for emergency administration whenever opioids are used. Additionally, this study provided physiologic data for servals anesthetized with a ketamine-medetomidine-butorphanol combination.
